In the current healthcare context, the importance of vitamin D3 has gained significant prominence, particularly in light of recent scientific studies. Osteoporosis is just one among the numerous conditions influenced by the deficiency of vitamin D3. This substance not only prevents the onset of bone diseases like osteoporosis and rachitis but also plays a crucial role in extra-skeletal pathologies, including diabetes and autoimmune diseases.

This growing need for effective and safe supplements opens a window of opportunity for raw material suppliers, emphasizing the latest technological and scientific advancements.

IPS, a supplier of microencapsulated raw material, offers one of the most innovative solutions in the market: microcapsules containing vitamin D3. The microencapsulation by coacervation is indeed a technique capable of enhancing the stability of vitamin D3 while simultaneously protecting it from oxidizing agents and increasing its availability. This means that the supplements will not only be more effective but also more versatile.

These microcapsules possess specific technicalities making them ideal for various types of formulations. The oil content ranges between 75% and 85%, with a density of 0.6 g/ml and a particle size ranging from 100 to 600 μm.

These characteristics are crucial for supplement manufacturers, enabling them to create products that perfectly cater to consumer needs. Whether it's hard capsules, monodose orodispersible sachets, or monodose vials with a dosing cap, IPS microcapsules offer an excellent solution to diversify and enhance the product offerings in the competitive supplement market.

By choosing IPS microcapsules containing vitamin D3, you're investing in a product that not only meets but exceeds consumer expectations. Technology and customer well-being should always go hand in hand, which is why IPS consistently invests resources and energy into scientific research and analyzing the current market.